Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorTimothy Mullett

About this trial

This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.

Eligibility criteria

Qualifiers

Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.

Willing to participate in the QUILS Index Assessment Survey process

Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews

Disqualifiers

Unwilling to participate in the QUILS Index Assessment Survey process

Unwilling to participate in the QUILS Audit Feedback presentations

Unwilling to participate in formative evaluation interviews

Trial design

Treatments tested in this trial

  • QUILS System

Treatment groups

330 Participants
are divided into 1 treatment group

Sponsors and collaborators

Timothy Mullett

Lead sponsor

University of Kentucky

Sponsor institution